YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Eli Lilly and Company, Pfizer, Sanofi, UCB, and more share learnings speeding drug development, connecting trials, and modernizing quality and manufacturing PLEASANTON, Calif., Oct. 8, 2026 /PRNewswire/ -- At Veeva R&D and Quality Summit o…
European equities traded in the US as American depositary receipts fell late Wednesday morning with PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium ne…
Company Logo Report Forecasts Plozasiran Sales Through 2034 Across Severe Hypertriglyceridemia, Familial Chylomicronemia Syndrome and Mixed Hyperlipidemia, Following Sanofi's Greater China Licensing Deal Dublin, Oct. 07, 2026 (GLOBE NEWSWI…
In early October 2026, Regeneron Pharmaceuticals reported new clinical data across oncology and obesity programs and expanded its long-running antibody alliance with Sanofi, which includes US$1.00 billion upfront and potential future miles…
[Close up image of wooden cubes with alphabet Q3 on office desk.] mohd izzuan * Days after announcing an expanded collaboration with its French partner Sanofi (SNY [https://seekingalpha.com/symbol/SNY]), Regeneron (REGN [https://seekingalp…
Novavax NVAX shares soared 20.1% in the last trading session to close at $12.56. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 2.4% gain over the past four we…
Sanofi Winthrop Industrie Availability of the aide-mémoire for Q3 2026 results Paris, France – October 6, 2026. Sanofi announced today the availability of the aide-mémoire for Q3 2026 results on the "Investors" page of sanofi.com: Third qu…
FutureBrand Hispanic America onboards Vicapsys and delivers a unified visual identity for Vicapsys Life Sciences and its Stateline subsidiary Two linked brands under one visual system: Vicapsys as the umbrella brand and Stateline as the op…
Wall Street closed in the green on Friday after the September nonfarm payrolls report came in cooler than economists expected. The blue-chip Dow ended up 0.5%, the benchmark S&P 500 gained 0.7%, and the tech-focused Nasdaq Composite advanc…
The six-time NBA All-Star, three-time All-NBA selection, 2016 NBA Rookie of the Year, and 2026 NBA Champion Karl-Anthony Towns brings his personal experience with COVID-19 to encourage eligible people, especially those at increased risk, t…
European equities traded in the US as American depositary receipts were trending higher late Friday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium ne…
Sanofi SNY and Regeneron Pharmaceuticals REGN announced that they have expanded their existing longstanding antibody collaboration to include four next-generation, long-acting antibodies targeting type II inflammation. More on the Latest S…
Shares of Sanofi (SNY [https://seekingalpha.com/symbol/SNY]) initially surged 3.6% in premarket trading before moderating to a 1% gain after the French pharmaceutical giant agreed [https://seekingalpha.com/pr/20670494-regeneron-and-sanofi-…
Investing.com -- Sanofi SA (EPA:SASY) will pay Regeneron $1 billion upfront and up to $7 billion in additional payments to expand their partnership on four new long-acting medicines for inflammatory diseases, as the French drugmaker looks…
Sanofi Winthrop Industrie Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies REGN20423, a clinical-stage long-acting IL-13 monoclonal antibody invented and developed by Regeneron, i…
Regeneron Pharmaceuticals, Inc. REGN20423, a clinical-stage long-acting IL-13 monoclonal antibody invented and developed by Regeneron, is added to the alliance, along with a long-acting IL-4xIL-13 bispecific and two other long-acting precl…
[Cantor And John Thune Hold Press Conference On Economy] Alex Wong/Getty Images News * The Pharmaceutical Research and Manufacturers of America (PhRMA) has selected former Republican House Majority Leader Eric Cantor as its next CEO and pr…
The liquidation auctioneer Liquidity Services is closing in on a buy point. The stock is up roughly 45% this year. Continue Reading
Teva Pharmaceutical Industries Limited's TEVA business was heavily dependent on generic medicines for decades. That model provided scale but also exposed the company to intense price competition, product commoditization and periodic revenu…
GSK GSK and Sanofi SNY are two major European drugmakers with diversified portfolios spanning vaccines, specialty medicines and other pharmaceutical products. GSK has a strong presence in specialty medicines, vaccines and general medicines…
Sanofi's SNY most important medicine remains its immunology drug, Dupixent, which continues to be the company's primary growth engine. Dupixent sales represented roughly 42% of Sanofi's first-half 2026 revenues. Sanofimarkets Dupixent in p…
Sanofi (ENXTPA:SAN) opened the Charles Best Building in Canada, described as the largest biomanufacturing investment in the country. The new Canadian site expands Sanofi's flu vaccine production capacity, with the goal of strengthening rea…
European equities traded in the US as American depositary receipts were tracking lower Wednesday mor PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Regeneron Pharmaceuticals' (NASDAQ: REGN) shares climbed well above $1,000 two years ago, reaching all-time highs. However, they have dropped significantly from those levels over the past 24 months and now sit slightly below $800 apiece. W…
Shares of Moderna MRNA rose 12% yesterday, even climbing to a new 52-week high of $176.86. The rally came as investors digested the company's announcement that it will present detailed data from the phase III INTerpath-001 study on intisme…
Company Logo Orphan drug demand is rising as genomics, biologics and personalized therapies advance, aided by faster approvals, government incentives, advocacy and improved rare-disease diagnosis. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) --…
Investing.com -- European assets may offer investors advantages that are being overlooked as markets remain heavily focused on U.S. technology leadership, according to Macquarie Global Strategy, which sees structural changes supporting str…
Choosing between Axsome Therapeutics (NASDAQ:AXSM) and Moderna (NASDAQ:MRNA) requires balancing rapid commercial expansion against the potential of a massive, multi-use technology platform during a period of industrial shift. Axsome focuse…
Corbus Pharmaceuticals CRBP has emerged as an unusual way for investors to gain exposure to the cannabis space. The company recently announced positive results from an early-stage study on its obesity candidate CRB-913, an oral cannabinoid…
Bavarian Nordic A/S COPENHAGEN, Denmark, September 17, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that Tarja Stenvall has been appointed President and Chief Executive Officer, effective October 15, 2026, succeeding Paul Chaplin…
Healthcare stocks were slightly lower late Wednesday afternoon, with the NYSE Healthcare Index fract PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
[A cardboard sign with the diagnosis of autism made of multicolored letters in the hands of a child on a purple background with pieces of colorful puzzles.] Maryna Auramchuk/iStock via Getty Images * HHS is expected to unveil an autism res…
The $925 million (CAD) expansion is adding end-to-end vaccine manufacturing capacity on Canadian soil Built in partnership with the Government of Canada, the Province of Ontario, and the City of Toronto to bolster the country's vaccine bio…
Earlier this month, Novavax participated in investor-focused healthcare conferences hosted by Citigroup and Cantor Fitzgerald in New York, outlining its vaccine and partnership positioning to a broad institutional audience. Around the same…
The race for pharmaceutical dominance often centers on chronic disease management. For investors, deciding between Novo Nordisk (NYSE:NVO) and Regeneron Pharmaceuticals (NASDAQ:REGN) requires a close look at their unique market strengths.…
Sanofi has delivered mixed returns over recent years, and with the share price around €75.43, the real issue for you is whether that level is justified by the earnings power the group is producing today. Over the past 3 years, the stock ha…